Navigation Links
OrthoAccel Technologies, Inc. Names U.S. National Sales Director
Date:5/30/2012

HOUSTON, May 30, 2012 /PRNewswire/ -- OrthoAccel Technologies, Inc., makers of AcceleDent™, a new device to accelerate orthodontic treatment, welcomes Christopher J. Bodish to the newly created position of United States National Sales Director. Mr. Bodish will oversee direct field sales in all United States market territories.

Taking this position is a natural career progression for him. Until recently, Mr. Bodish worked with OrthoAccel as a consultant. He brings to the position vast experience and a remarkably successful track record in sales and sales management. During his thirty years in the orthodontic industry he's made countless contributions to the field, including a long and distinguished career with perennial market leader DENTSPLY GAC International.

Mr. Bodish will report to Dwight Schnaitter, Vice President of Sales, who comments, "The most exciting attribute Chris brings to OrthoAccel is his leadership. He carries forward proven success in managing many of the areas that will require our focus. These include territory growth, talent recruitment and training, opinion leader management, and commitment to an educational and partnership-based selling approach."

In related news, OrthoAccel was pleased to introduce AcceleDent at the 112th Annual Session of the American Association of Orthodontists, held May 4–8 in Honolulu. OrthoAccel's exhibit included an international kiosk, complemented by a theatre setting for presenting a series of educational "microlectures" on a number of subjects, including the scientific and clinical evidence supporting AcceleDent.

In order to accommodate growth, the Houston-based company recently finalized plans to move to a larger facility.

About OrthoAccel® Technologies, Inc.

OrthoAccel's AcceleDent™ product provides faster tooth movement through its FDA approved solution, available now in over fifteen countries around the world.  AcceleDent™ works with all existing orthodontic solutions, including standard brackets and aligners, requiring only twenty minutes per day of regular usage.  OrthoAccel was founded in 2007 to commercialize research conducted by Dr. Jeremy Mao, DDS, PhD and Professor, Columbia University College of Dental Medicine.


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
2. OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
3. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
4. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
5. AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
6. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
7. Cell Therapy - Technologies, Markets and Companies
8. Cytogenetics - Technologies, Markets and Companies
9. Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Biomarkers - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)...  Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, parks ... head lice treatment salon to set up shop. But there,s ... a French bistro on E Madison Ave, and CEO ... old lice clinic, we pride ourselves on being a destination ... of the stigma associated with lice. Everyone can get lice ...
(Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
(Date:2/23/2017)... ... , ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC ... GGI's mission is to advance global health and highlight the greater good of clinical ... each clinical trial volunteer. The vision of GGI is to serve as a philanthropic ...
(Date:2/23/2017)... and SAN FRANCISCO , Feb. 23, ... medicine company, and Beyond Type 1, a not-for-profit advocacy ... diabetes, today announced a grant from Beyond Type 1 ... for type 1 and other insulin-requiring diabetes.  ... developing innovative stem cell-derived cell replacement therapies with a ...
Breaking Biology Technology:
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
Breaking Biology News(10 mins):